Inotiv, Inc. — Director's Dealing 2004

Apr 5, 2004

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2004-04-01

Reporting Person: COX MICHAEL R (V.P. Finance, CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2004-04-01	Option to Buy Common Shares	$4.58	A	25000	Acquired	2014-04-01	Common Shares (25000)	Direct
2004-04-01	Option to Buy Common Shares	$4.58	A	25000	Acquired	2014-04-01	Common Shares (25000)	Direct

Footnotes

F1: 50% of the grant is exercisable one (1) year after the grant date the remaining 50% is exercisable three (3) years after the grant date.

F2: 50% of the grant is exercisable six (6) months after the grant date and 50% one year after the grant date.